The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.


Updates from The Motley Fool

Latest updates on SPDR S and P Pharmaceuticals from Fool.com.
These 3 ETFs Jumped in November

Pharma stocks fared well in November. Image: Pixabay. Continued volatility in the stock market le...

These ETFs Could Make You Rich

From their humble beginning almost 20 years ago, exchange-traded funds have become one of the ...



Stock Performance

View Interactive XPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about SPDR S and P Pharmaceuticals.
Current Price: $38.77
Prev Close: $38.25
Open: $38.45
Bid: $38.54
Ask: $39.21
Day's Range: $38.45 - $39.15
52wk Range: $36.58 - $55.01
Volume: 466,661
Avg Vol 377,977
Market Cap: $500M
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.29 (0.6%)

Company Rating

What our community thinks about SPDR S and P Pharmaceuticals.
CAPS Rating 3 out of 5
 
29 Outperform
6 Underperform
CAPS All Stars
 
6 Outperform
2 Underperform

How do you think SPDR S and P Pharmaceuticals will perform against the market?



You pick for SPDR S and P Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for SPDR S and P Pharmaceuticals.

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.

  • Exchange: NYSEMKT
  • Sector: Sector Equity
  • Industry: Health/Biotechnology Funds